Table 2.
Reported lifetime use, n (%) | |
---|---|
Stimulants | 6 (6.3%) |
Antidepressants | 74 (78.7%) |
Anxiolytics | 29 (31.2%) |
Hypnotics | 17 (18.1%) |
Mood stabilisers | 6 (6.5%) |
Antipsychotics | 25 (26.3%) |
Reported psychotropic medication usage in participants with ASD based on the National Centre for Mental Health questionnaire response fields. n indicates the number of individuals reporting usage of medication of this type; % indicates the percentage of the total amount of participants that responded.
ASD, autism spectrum disorder.